GL1X · GenesisL1 explorer

Research workbench

X-ray co-structure of nuclear receptor ror-gammat ligand binding domain with an agonist and SRC2 peptide

Analyse X-ray co-structure of nuclear receptor ror-gammat ligand binding domain with an… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5VB7
Type
protein
Length
259 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Nuclear receptor ror-gamma, SRC2 chimera
UniProt
P51449
Ligands
921, NA
Pockets
4 · best druggability 0.83

Structure

x-ray diffraction · 1 distinct chain · 73% helix, 4% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ANuclear receptor ror-gamma, SRC2 chimeraprotein25973% helix, 4% strandP51449

Ligands and binding sites

  • 921 · N-methyl-N'-(3-methylbut-2-en-1-yl)-N'-(3-phenoxyphenyl)-N-[trans-4-(pyridin-4-yl) cyclohexyl]urea · ligand · chains A
  • NA · Sodium ion · metal · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14040.830.9138921
21490.530.8020empty
3650.400.8013NA
4820.330.7418empty

Compared structures

  • 5VB7 · X-ray co-structure of nuclear receptor ROR-gammat Ligand Binding Domain with an agonist… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.